ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison.

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison – ESC Heart Failure

Original Guidelines:

#ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.

#ESCCongress – 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure – SGLT2 inhibitors are now recommended for patients with heart failure with reduced ejection fraction regardless of the presence of diabetes.